Kyverna Therapeutics, Inc.

KYTX · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.5B · 130 employees
53
SEC Filings
$8.35
Close 2026-09-03
130
Employees

Business Summary

Kyverna Therapeutics, Inc. (KYTX) is a clinical-stage biopharmaceutical company focused on developing cell therapies for autoimmune diseases. The company is advancing product candidates through preclinical studies and clinical trials, leveraging CAR-T and other cell therapy platforms. Kyverna aims to treat patients with serious autoimmune conditions, with plans for regulatory filings and potential commercialization of its pipeline candidates.

Latest Stock Quote

KYTX 2026-09-03 $8.35 O:$8.71 H:$8.78 L:$8.28 Vol:0.6M VWAP:$8.4463
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-18

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-262025-12-310001193125-26-126242EDGAR130K words
2025-03-272024-12-310000950170-25-046074EDGAR128K words
2024-03-262023-12-310000950170-24-036481EDGAR130K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-112026-06-300001193125-26-344607EDGAR81K words
2025-11-122025-09-300001193125-25-277584EDGAR80K words
2025-08-122025-06-300000950170-25-107321EDGAR78K words
2025-05-132025-03-310000950170-25-070325EDGAR74K words
2024-11-132024-09-300000950170-24-126366EDGAR77K words
2024-08-122024-06-300000950170-24-095462EDGAR75K words
2024-05-142024-03-310000950170-24-059628EDGAR74K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-240001193125-26-400062EDGAR2K words
2026-08-110001193125-26-344572EDGAR2K words
2026-07-270001193125-26-316916EDGAR1K words
2026-03-260001193125-26-126216EDGAR3K words
2026-02-240001193125-26-065320EDGAR1K words
2026-02-030001193125-26-034464EDGAR1K words
2026-01-120001193125-26-009810EDGAR1K words
2025-12-180001213900-25-123033EDGAR1K words
2025-12-150001193125-25-318469EDGAR3K words
2025-12-150001193125-25-318377EDGAR2K words

53 total filings indexed. 33 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

autoimmune-diseases cell-therapy

Company Identity

CIK0001994702
TickerKYTX
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.kyvernatx.com
Listed2024-02-08

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: d562b705ab0b7dd3aaa49aebde4dae23cb72acdd7053f015c9d4ce24ac9564f8
parent: d347383ebc536b60bbeda5636ffa6c3009675f8053d7601545bf599517ed9104
content hash: b41ffa82c66454ec3e474bd232069003fabe6eaa29b48f197249e43e25c8eaab
signed: 2026-09-28T19:01:57.276Z
sources: 10 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up KYTX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on KYTX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/KYTX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.